113 related articles for article (PubMed ID: 6143285)
1. Biochemistry of the hypothalamus in Parkinson's disease.
Javoy-Agid F; Ruberg M; Pique L; Bertagna X; Taquet H; Studler JM; Cesselin F; Epelbaum J; Agid Y
Neurology; 1984 May; 34(5):672-5. PubMed ID: 6143285
[TBL] [Abstract][Full Text] [Related]
2. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects.
Shannak K; Rajput A; Rozdilsky B; Kish S; Gilbert J; Hornykiewicz O
Brain Res; 1994 Mar; 639(1):33-41. PubMed ID: 8180836
[TBL] [Abstract][Full Text] [Related]
3. The hypothalamus in Parkinson disease.
Sandyk R; Iacono RP; Bamford CR
Ital J Neurol Sci; 1987 Jun; 8(3):227-34. PubMed ID: 2887537
[TBL] [Abstract][Full Text] [Related]
4. Biochemical neuropathology of Parkinson's disease.
Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
[No Abstract] [Full Text] [Related]
5. Changes in hypothalamic neurotransmitter uptake following pinealectomy, superior cervical ganglionectomy or melatonin administration to rats.
Cardinali DP
Neuroendocrinology; 1975; 19(1):91-5. PubMed ID: 1692
[TBL] [Abstract][Full Text] [Related]
6. Brain amine concentrations after monoamine oxidase inhibitor administration.
Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Parkinson's disease.
Br Med J; 1978 Apr; 1(6117):872-3. PubMed ID: 25109
[No Abstract] [Full Text] [Related]
8. Neurotransmitter levels in the hypothalamus during postnatal development of rats.
Macho L; Kvetnanský R; Culman J; Ficková M
Exp Clin Endocrinol; 1986 Dec; 88(2):142-50. PubMed ID: 2881796
[TBL] [Abstract][Full Text] [Related]
9. [Progresses in the study of unbalance of basal ganglia neurotransmitters in Parkinson's disease].
Sun ZL; Jia J; Yu F
Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):427-30. PubMed ID: 22363981
[No Abstract] [Full Text] [Related]
10. Dose-related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonin neurotransmission.
Vécsei L; Kovács GL; Faludi M; Bollók I; Telegdy G
Acta Physiol Hung; 1985; 66(2):213-7. PubMed ID: 2864776
[TBL] [Abstract][Full Text] [Related]
11. Brain neurotransmitters and neuropeptides in Parkinson's disease.
Rinne UK; Rinne JO; Rinne JK; Laakso K; Lönnberg P
Acta Physiol Pharmacol Latinoam; 1984; 34(3):287-99. PubMed ID: 6099688
[TBL] [Abstract][Full Text] [Related]
12. Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus.
Hökfelt T; Elde R; Fuxe K; Johansson O; Ljungdahl A; Goldstein M; Luft R; Efendic S; Nilsson G; Terenius L; Ganten D; Jeffcoate SL; Rehfeld J; Said S; Perez de la Mora M; Possani L; Tapia R; Teran L; Palacios R
Res Publ Assoc Res Nerv Ment Dis; 1978; 56():69-135. PubMed ID: 23576
[No Abstract] [Full Text] [Related]
13. Aging effects on hypothalamic dopamine and norepinephrine content in the male rat.
Miller AE; Shaar CJ; Riegle GD
Exp Aging Res; 1976 Sep; 2(5):475-80. PubMed ID: 1017462
[TBL] [Abstract][Full Text] [Related]
14. Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus.
Brunetti L; Ferrante C; Orlando G; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Shohreh R; Manippa F; Ricciuti A; Mollica A; Vacca M
Peptides; 2013 Oct; 48():83-8. PubMed ID: 23916912
[TBL] [Abstract][Full Text] [Related]
15. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease.
Matzuk MM; Saper CB
Ann Neurol; 1985 Nov; 18(5):552-5. PubMed ID: 4073850
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitters and hypothalamic hormones in the central nervous system.
Brownstein M
Fed Proc; 1977 Jun; 36(7):1960-3. PubMed ID: 16784
[No Abstract] [Full Text] [Related]
17. [Effect of monoamine neurotransmitters in the hypothalamus in a cortisol-induced rat model of yang-deficiency].
Chen M; Kuang A; Chen J
Zhong Xi Yi Jie He Za Zhi; 1990 May; 10(5):292-4, 262. PubMed ID: 1975774
[TBL] [Abstract][Full Text] [Related]
18. The biochemistry of the basal ganglia and Parkinson's disease.
Curzon G
Postgrad Med J; 1977 Dec; 53(626):719-25. PubMed ID: 24209
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic monoamine levels and gonadotrophin secretion following deafferentation of the medial basal hypothalamus.
Weiner RI
Prog Brain Res; 1973; 39():165-70. PubMed ID: 4151255
[No Abstract] [Full Text] [Related]
20. [Effect of electroacupuncture at different acupoints on hormones and neurotransmitters of hypotha- lamic-pituitary-adrenal axis in rats under simulated weightlessness].
Zhang H; Zhao G; Wang D; Zhao B; Ji B; Song Y; Zhang P; Liu Y; Li Y
Zhongguo Zhen Jiu; 2015 Dec; 35(12):1275-9. PubMed ID: 26964178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
